Form 4 for AVY Avery Dennison
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001127602-25-008037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-03-04 | 2025-03-01 | AVY | Allouche Danny Gilad | SVP, CSDO, Interim CFO | F - Tax | $187.06 | -979 | 19.1K | -5% | -$183.1K |
| DMI | 2025-03-04 | 2025-03-01 | AVY | Allouche Danny Gilad | SVP, CSDO, Interim CFO | M - OptEx | $187.06 | +2,223 | 20.2K | +12% | +$415.8K |
| DM | 2025-03-04 | 2025-03-01 | AVY | Allouche Danny Gilad | SVP, CSDO, Interim CFO | A - Grant | $0.00 | +7,700 | 2,673 | New | $0 |
| DM | 2025-03-04 | 2025-03-01 | AVY | Allouche Danny Gilad | SVP, CSDO, Interim CFO | M - OptEx | $0.00 | -2,223 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | F | D | 86 | $187.06 | 19,395 | I Trust | — | — | |
| 2 | Common | Common Stock | 2025-03-01 | M | A | 233 | $187.06 | 19,481 | I Trust | — | — | |
| 3 | Common | Common Stock | 2025-03-01 | F | D | 165 | $187.06 | 19,248 | I Trust | — | — | |
| 4 | Common | Common Stock | 2025-03-01 | F | D | 357 | $187.06 | 19,849 | I Trust | — | — | |
| 5 | Common | Common Stock | 2025-03-01 | M | A | 345 | $187.06 | 19,413 | I Trust | — | — | |
| 6 | Common | Common Stock | 2025-03-01 | M | A | 376 | $187.06 | 18,981 | I Trust | — | — | |
| 7 | Common | Common Stock | 2025-03-01 | F | D | 169 | $187.06 | 18,812 | I Trust | — | — | |
| 8 | Common | Common Stock | 2025-03-01 | M | A | 458 | $187.06 | 19,270 | I Trust | — | — | |
| 9 | Common | Common Stock | 2025-03-01 | F | D | 202 | $187.06 | 19,068 | I Trust | — | — | |
| 10 | Common | Common Stock | 2025-03-01 | M | A | 811 | $187.06 | 20,206 | I Trust | — | — | |
| 11 | Derivative | 2025 MSU Award | 2025-03-01 | A | A | 2,463 | $0.00 | 2,463 | D | $0.00 · 2026-03-01 to 2029-03-01 | 2,463 Common Stock | (F1) Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
| 12 | Derivative | 2025 PU Award | 2025-03-01 | A | A | 2,564 | $0.00 | 2,564 | D | $0.00 · 2028-03-01 to 2028-03-01 | 2,564 Common Stock | (F2) Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock. |
| 13 | Derivative | 2025 Promotion RSU Award | 2025-03-01 | A | A | 2,673 | $0.00 | 2,673 | D | $0.00 · 2028-03-01 to 2028-03-01 | 2,673 Common Stock | (F3) Restricted stock units (RSUs) cliff vest on the third anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| 14 | Derivative | 2021 MSU Award | 2025-03-01 | M | D | 376 | $0.00 | 0 | D | $0.00 · 2022-03-01 to 2025-03-01 | 376 Common Stock | (F4) Shares reflect the vesting of the fourth tranche of MSUs granted in February 2021 at 128% of target based on our absolute total stockholder return in excess of 10% during the 2021-2024 performance period, plus dividend equivalents accrued during the period. |
| 15 | Derivative | 2022 MSU Award | 2025-03-01 | M | D | 458 | $0.00 | 473 | D | $0.00 · 2023-03-01 to 2026-03-01 | 458 Common Stock | (F5) Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period. |
| 16 | Derivative | 2023 MSU Award | 2025-03-01 | M | D | 345 | $0.00 | 696 | D | $0.00 · 2024-03-01 to 2027-03-01 | 345 Common Stock | (F6) Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period. |
| 17 | Derivative | 2024 MSU Award | 2025-03-01 | M | D | 233 | $0.00 | 742 | D | $0.00 · 2025-03-01 to 2028-03-01 | 233 Common Stock | (F7) Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period. |
| 18 | Derivative | 2022 PU Award | 2025-03-01 | M | D | 811 | $0.00 | 0 | D | $0.00 · 2025-03-01 to 2025-03-01 | 811 Common Stock | (F8) Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target. |